These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Roles of mu, delta and kappa opioid receptors in spinal and supraspinal mediation of gastrointestinal transit effects and hot-plate analgesia in the mouse. Porreca F; Mosberg HI; Hurst R; Hruby VJ; Burks TF J Pharmacol Exp Ther; 1984 Aug; 230(2):341-8. PubMed ID: 6086883 [TBL] [Abstract][Full Text] [Related]
5. Action at the mu receptor is sufficient to explain the supraspinal analgesic effect of opiates. Fang FG; Fields HL; Lee NM J Pharmacol Exp Ther; 1986 Sep; 238(3):1039-44. PubMed ID: 3018217 [TBL] [Abstract][Full Text] [Related]
7. Multiplicative interaction between intrathecally and intracerebroventricularly administered mu opioid agonists but limited interactions between delta and kappa agonists for antinociception in mice. Roerig SC; Fujimoto JM J Pharmacol Exp Ther; 1989 Jun; 249(3):762-8. PubMed ID: 2567350 [TBL] [Abstract][Full Text] [Related]
8. Antidiarrheal properties of supraspinal mu and delta and peripheral mu, delta and kappa opioid receptors: inhibition of diarrhea without constipation. Shook JE; Lemcke PK; Gehrig CA; Hruby VJ; Burks TF J Pharmacol Exp Ther; 1989 Apr; 249(1):83-90. PubMed ID: 2540324 [TBL] [Abstract][Full Text] [Related]
9. Spinal involvement of both dynorphin A and Met-enkephalin in the antinociception induced by intracerebroventricularly administered bremazocine but not morphine in the mouse. Tseng LF; Collins KA J Pharmacol Exp Ther; 1993 Sep; 266(3):1430-8. PubMed ID: 8103794 [TBL] [Abstract][Full Text] [Related]
10. Dissociation of opioid antinociception and central gastrointestinal propulsion in the mouse: studies with naloxonazine. Heyman JS; Williams CL; Burks TF; Mosberg HI; Porreca F J Pharmacol Exp Ther; 1988 Apr; 245(1):238-43. PubMed ID: 2834537 [TBL] [Abstract][Full Text] [Related]
11. The antinociception produced by intrathecal morphine, calcium, A23187, U50,488H, [D-Ala2, N-Me-Phe4, Gly-ol]enkephalin and [D-Pen2, D-Pen5]enkephalin after intrathecal administration of calcitonin gene-related peptide in mice. Welch SP; Singha AK; Dewey WL J Pharmacol Exp Ther; 1989 Oct; 251(1):1-8. PubMed ID: 2552070 [TBL] [Abstract][Full Text] [Related]
12. Role of mu and delta receptors in the supraspinal and spinal analgesic effects of [D-Pen2, D-Pen5]enkephalin in the mouse. Porreca F; Heyman JS; Mosberg HI; Omnaas JR; Vaught JL J Pharmacol Exp Ther; 1987 May; 241(2):393-400. PubMed ID: 3033214 [TBL] [Abstract][Full Text] [Related]
13. Indirect involvement of delta opioid receptors in cholecystokinin octapeptide-induced analgesia in mice. Hong EK; Takemori AE J Pharmacol Exp Ther; 1989 Nov; 251(2):594-8. PubMed ID: 2553928 [TBL] [Abstract][Full Text] [Related]
14. Lack of morphine and enkephalin tolerance in 129/SvEv mice: evidence for a NMDA receptor defect. Kolesnikov Y; Jain S; Wilson R; Pasternak GW J Pharmacol Exp Ther; 1998 Feb; 284(2):455-9. PubMed ID: 9454784 [TBL] [Abstract][Full Text] [Related]
15. The competitive alpha-amino-3-hydroxy-5-methylisoxazole-4-propionate receptor antagonist LY293558 attenuates and reverses analgesic tolerance to morphine but not to delta or kappa opioids. Kest B; McLemore G; Kao B; Inturrisi CE J Pharmacol Exp Ther; 1997 Dec; 283(3):1249-55. PubMed ID: 9400000 [TBL] [Abstract][Full Text] [Related]
16. Ketamine- and morphine-induced analgesia and catalepsy. I. Tolerance, cross-tolerance, potentiation, residual morphine levels and naloxone action in the rat. Winters WD; Hance AJ; Cadd GG; Quam DD; Benthuysen JL J Pharmacol Exp Ther; 1988 Jan; 244(1):51-7. PubMed ID: 3336011 [TBL] [Abstract][Full Text] [Related]
17. DynorphinA-(2-17) restores spinal/supraspinal morphine synergy in morphine-tolerant mice. He L; Lee NM J Pharmacol Exp Ther; 1997 Mar; 280(3):1210-4. PubMed ID: 9067305 [TBL] [Abstract][Full Text] [Related]
18. Pretreatment with pertussis toxin differentially modulates morphine- and beta-endorphin-induced antinociception in the mouse. Tseng LF; Collins KA J Pharmacol Exp Ther; 1996 Oct; 279(1):39-46. PubMed ID: 8858973 [TBL] [Abstract][Full Text] [Related]